Hyloris Pharmaceuticals SA announced the appointment of Dr. Dietmar Aichhorn as Chief Operating Officer, with effect from 1 October 2020. Dr. Dietmar Aichhorn, PhD, is a chemical engineer with over 20 years of experience in the pharmaceutical industry. Most recently, Dr. Dietmar Aichhorn had an assignemt at Polpharma Biologics, where he was responsible for the clinical development of monoclonal antibodies, as well as overseeing scientific affairs. In this newly created role, Dr. Dietmar Aichhorn will be responsible for leading the development of Hyloris’ growing product portfolio.